ACLY and neoplasm: As these tumour-suppressive effects in the Acly KO occurred independently of changes in liver histology, and the TTR-Cre promoter used to induce deletion does not affect immune cells26, these studies provide surprising findings about how inhibiting ACLY not only suppresses tumour proliferation but also enhances immunogenicity.